Clearstead Advisors’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$292 Sell
52
-117
-69% -$734 ﹤0.01% 3015
2026
Q2
$961 Buy
+169
New +$826 ﹤0.01% 2708
2026
Q1
– Sell
-30
Closed -$269 – 2661
2025
Q4
$269 Sell
30
-1,205
-98% -$7.46K ﹤0.01% 2391
2025
Q3
$4.57K Buy
1,235
+744
+152% +$2.03K ﹤0.01% 2188
2025
Q2
$958 Buy
+491
New +$1.02K ﹤0.01% 2436

Other funds holding NUVB

Clearstead Advisors's NUVB Position: Q3 2026 in Review

Clearstead Advisors reduced its Nuvation Bio (NUVB) stake by 69% in Q3 2026, selling an estimated $734 and leaving 52 shares worth $292. The position accounts for ﹤0.01% of the portfolio, ranked #3015.

Clearstead Advisors first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.57K in Q3 2025. 259 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Clearstead Advisors held 52 shares of Nuvation Bio worth $292 as of Q3 2026.
  • Clearstead Advisors sold 117 Nuvation Bio shares in Q3 2026, an estimated $734.
  • Nuvation Bio made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #3015 holding.
  • Clearstead Advisors first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • Clearstead Advisors's Nuvation Bio position peaked at $4.57K in Q3 2025.
  • 259 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.